Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa

• Published in: Clinical and experimental allergy Vol. 32; no. 7; pp. 1007 - 1012
• Main Authors: Shirasaki, H., Kanaizumi, E., Watanabe, K., Matsui, T., Sato, J., Narita, S., Rautiainen, M., Himi, T.
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Science Ltd 01.07.2002; Blackwell; Wiley Subscription Services, Inc
• Subjects: Adolescent; Adult; Biological and medical sciences; CysLT1 receptor; CysLT2 receptor; Female; Humans; Immunohistochemistry; In Situ Hybridization; Leukotriene D4 - pharmacology; Male; Medical sciences; Membrane Proteins; Middle Aged; nasal mucosa; Nasal Mucosa - chemistry; Nasal Mucosa - metabolism; Non tumoral diseases; Otorhinolaryngology. Stomatology; Receptors, Leukotriene - analysis; Receptors, Leukotriene - genetics; Reverse Transcriptase Polymerase Chain Reaction; Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology; Human; CysLT1 leukotriene receptor; Immunopathology; Allergy; Nose disease; Rhinitis; Pathogenesis; Mucosa; Nose; ENT disease; CysLT2 leukotriene receptor
• ISSN: 0954-7894; 1365-2222
• DOI: 10.1046/j.1365-2222.2002.01425.x

Summary Background The cysteinyl leukotrienes (CysLT) are lipid mediators that have been implicated in the pathogenesis of allergic diseases. Pharmacological studies using CysLTs indicate that two classes of receptors, named CysLT1 and CysLT2 receptor, exist. The former is sensitive to the CysLT1 antagonist currently used to treat asthma and allergic rhinitis. Recently, the cDNA for human CysLT1 and CysLT2 receptor have been cloned, making it now possible to study the gene expression of CysLTs receptors. Objective We have used reverse transcription and polymerase chain reaction (RT‐PCR) to study the gene expression of CysLT1 and CysLT2 receptor and in situ hybridization to determine the distribution of CysLT1 receptor mRNA in human nasal mucosa. In addition, the distribution of the CysLT1 receptor protein was studied by immunohistochemistry. Methods Human turbinates were obtained after turbinectomy from six patients with nasal obstruction refractory to medical therapy. Total RNA was isolated from human nasal mucosa and both CysLT1 and CysLT2 receptor mRNA was detected in these tissues by using RT‐PCR. For in situ hybridization study of human nasal mucosa, we used biotin‐labelled oligonucleotides probes encoding human CysLT1 receptor cDNA. To identify the cells expressing the CysLT1 receptor protein, double immunostaining was performed by using anti‐CysLT1 receptor antibody and monoclonal antileucocyte antibodies. Results RT‐PCR analysis of total nasal RNA demonstrated the expression of both CysLT1 receptor and CysLT2 receptor mRNA. In situ hybridization indicated high levels of CysLT1 receptor hybridization in blood vessels and the interstitial cells, but a sparse signal in airway epithelium and submucosal glands. The immunohistochemical studies revealed that anti‐CysLT1 receptor antibody labelled eosinophils, mast cells, macrophages, neutrophils and vascular endothelial cells in the nasal mucosa. Conclusion The results may have an important clinical implication and also promote further investigation of the regulation of CysLT1 receptor in health and disease.